MabCure, Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure, Inc. in January 2008 to reflect its new business plan. MabCure, Inc. was founded in 2006 and is based in White Plains, New York.
Frequently asked questions
What sector does MabCure Inc (MBCI) operate in?
MabCure Inc belongs to the Information Technology sector and operates in the Solar industry.
What is MabCure Inc (MBCI) current stock price?
As of the latest data, MabCure Inc stock price is $0.00, with a previous close of $0.00.
What is MabCure Inc (MBCI) current market capitalization?
MabCure Inc market cap is approximately 78.11.
Does MabCure Inc (MBCI) pay dividends?
No. MabCure Inc does not pay a dividend.
What is MabCure Inc (MBCI) beta (volatility) score?
MabCure Inc has a beta of -25.174, indicating lower volatility than the overall market.